Vaccination against COVID-19 has emerged as one of the strongest keys in resuming a normal life, post-pandemic. While booster shots are being currently looked into, several researchers are now delving ...

A phase one trial of a multivariant COVID-19 vaccine booster drug has got underway among participants aged over 60 in the UK. The trial, involving GRT-R910, has been launched by US pharmaceutical ...

Based on the results, the trial is now being expanded to 120 people, potentially enabling more rapid advancement into a later stage trial ...

A COVID-19 vaccine that could work against multiple variants of the coronavirus – developed by US biotech Gritstone bio – has generated encouraging immune response data in its first clinical trial.

It is never easy to know what will work with a social media post, a blog title or a set up of a website. So you sould always test. Here we explain AB testing and Multivariate testing. #marketing ...